Biotech China 2014

Leukemia: University of Chicago

Total Score People Score Events Score
28 21 12
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Molecular Pathways in Head and Neck Cancer Tanguy Y Seiwert
Beyond Progression: Treating EGFR, ALK-Positive Non-Small Cell Lung Cancer after First-Line Therapy Robert C. Doebele
Strategies to Overcome Clinical, Regulatory, and Financial Challenges in Implementation of Personalized Medicine Richard L Schilsky
Education Sessions Hedy L. Kindler
Special Session Richard L Schilsky
April 6, 2013 AACR Annual Meetings Innate Immune Sensing in the Tumor Microenvironment Chairperson: Thomas Frank Gajewski, University of Chicago, Chicago, IL Thomas F Gajewski
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Thomas F Gajewski
Cancer Methylomes for Biomarker and Pathway Discovery Chairperson: Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo, Japan Chuan He
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Special Symposium on Epigenetics in Hematopoiesis Lucy A. Godley
Career-Development Lunch Sessions Michelle M. Le Beau
April 12, 2011 New Insights into Normal versus Dysregulated B Cell Function (D6) The Regulatory and Molecular Logic of IL-7R and pre-BCR Signaling in B Cell Development Harinder Singh
The Human B Cell Response to Annual and H1N1 Influenza Virus Patrick C. Wilson
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) The Leukemic Stem Cell Niche Dorothy A. Sipkins
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma mTOR Inhibitors Sonali M. Smith
September 11, 2010 New Advances in Inflammatory Bowel Disease Extra-intestinal Manifestations of Inflammatory Bowel Disease Russell D. Cohen
Q&A / Panel Discussion David T. Rubin
New Concepts in the Detection and Management of Dysplasia in Ulcerative Colitis David T. Rubin
Q&A / Panel Discussion Russell D. Cohen
Q&A / Panel Discussion David T. Rubin
Should Biologics Be Used Alone or With Immunomodulators? David T. Rubin
January 22, 2010 Highlights of American Society of Hematology® Panel Discussion: Richard A. Larson
Acute Myeloid Leukemia: New Therapeutic Targets Richard A. Larson
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Pharmacogenomics in Anticancer Therapy Federico Innocenti
Pharmacogenomics of Angiogenesis Inhibitors Federico Innocenti
Whole Genome Association Studies to Identify Pharmacogenetic Signatures M. Eileen Dolan
June 27, 2008 American Society of Clinical Oncology Program Commitee Richard L Schilsky, Walter Michael Stadler
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
clinical trials-- Grant Writing Workshop Richard L Schilsky
developmental therapeutics-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Rectal Cancer (CPO17A) Bruce Minsky
gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Rectal Cancer (CPO17B) Bruce Minsky
genitourinary cancer-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
leukemia, myelodysplasia, and transplantation-- Advances in Acute Leukemia Therapy Wendy Stock
lung cancer-- New Developments in Management of Malignant Mesothelioma Hedy L. Kindler
lung cancer-- Optimal Management of Stage III Non-Small Cell Lung Cancer (M17) Everett E Vokes
melanoma/skin cancers-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
tumor biology-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
tumor biology-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
meet the professor sessions-- Optimal Management of Stage III Non-Small Cell Lung Cancer (M17) Everett E Vokes
clinical problems in oncology-- The Multidisciplinary Management of Rectal Cancer (CPO17A) Bruce Minsky
clinical problems in oncology-- The Multidisciplinary Management of Rectal Cancer (CPO17B) Bruce Minsky
October 11, 2007 Sixth International Colorectal Cancer Congress Optimizing Radiotherapy for Rectal Cancer Bruce Minsky
Multidisciplinary Management for Timing of Rectal Surgery Bruce Minsky
Role of UGT1A1 as a Determinant of Irinotecan Toxicity Federico Innocenti
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.